You just read:

Lakewood-Amedex Inc. Reports Positive Top-Line Data from Randomized Controlled Phase 1/2a Trial of Nu-3 Antimicrobial in Patients with Infected Diabetic Foot Ulcers

News provided by

Lakewood-Amedex Inc.

Sep 27, 2017, 07:11 ET